QQ客服 官方微博 反馈留言

	psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling
	Ding, Jin[1]; Wen, Wen[1]; Xiang, Daimin[1]; Yin, Peipei[1,2]; Liu, Yanfang[3]; Liu, Chang[2]; He, Guoping[1]; Cheng, Zhuo[1]; Yin, Jianpeng[5]; Sheng, Chunquan[4]
	2015
卷号	6期号:13页码:11627
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4347732
专题	暨南大学
作者单位	1.[1]Second Mil Med Univ, Int Cooperat Lab Signal Transduct, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China 2.[2]Shanghai Inst Pharmaceut Ind, Dept Pharmacol, Shanghai, Peoples R China 3.[3]Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China 4.[4]Second Mil Med Univ, Coll Pharm, Shanghai, Peoples R China 5.[5]Natl Ctr Drug Screen, Shanghai, Peoples R China 6.[6]Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China 7.[7]Natl Ctr Liver Canc, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Ding, Jin[1],Wen, Wen[1],Xiang, Daimin[1],et al. psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling[J],2015,6(13):11627.
APA	Ding, Jin[1].,Wen, Wen[1].,Xiang, Daimin[1].,Yin, Peipei[1,2].,Liu, Yanfang[3].,...&Wang, Hongyang[1,7].(2015).psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.,6(13),11627.
MLA	Ding, Jin[1],et al."psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling".6.13(2015):11627.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。